Bridgeway Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.6M Hold
66,100
0.06% 383
2026
Q1
$2.84M Sell
66,100
-15,000
-18% -$645K 0.06% 415
2025
Q4
$3.55M Sell
81,100
-550
-0.7% -$22.8K 0.07% 332
2025
Q3
$3.37M Buy
81,650
+16,950
+26% +$681K 0.07% 365
2025
Q2
$2.85M Sell
64,700
-3,300
-5% -$132K 0.07% 398
2025
Q1
$2.51M Hold
68,000
0.06% 425
2024
Q4
$2.26M Buy
+68,000
New +$2.21M 0.05% 490

Other funds holding EXEL

Bridgeway Capital Management's EXEL Position: Q2 2026 in Review

Bridgeway Capital Management held its Exelixis (EXEL) position steady in Q2 2026 at 66,100 shares worth $3.6M. The position accounts for 0.06% of the portfolio, ranked #383.

Bridgeway Capital Management first reported a position in EXEL in Q4 2024 and has held it in 7 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Bridgeway Capital Management held 66,100 shares of Exelixis worth $3.6M as of Q2 2026.
  • Bridgeway Capital Management left its Exelixis share count unchanged in Q2 2026.
  • Exelixis made up 0.06% of Bridgeway Capital Management's portfolio in Q2 2026, its #383 holding.
  • Bridgeway Capital Management first reported a position in Exelixis in Q4 2024 and has held it in 7 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.